anti-PTK6 Protein tyrosine Kinase 6 (PTK6) Antikörper

The protein encoded by PTK6 is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Zusätzlich bieten wir Ihnen PTK6 Proteine (15) und PTK6 Kits (13) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
PTK6 5753 Q13882
PTK6 20459 Q64434
PTK6 366275  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-PTK6 Antikörper auf antikoerper-online.de

Showing 10 out of 163 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Pferd Kaninchen Unkonjugiert WB WB Suggested Anti-PTK6 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:1562500Positive Control: HepG2 cell lysate 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Human Kaninchen Unkonjugiert WB 100 μg Anmelden zum Anzeigen 2 bis 3 Tage
$245.00
Details
Human Kaninchen Unkonjugiert IF, ELISA, WB Western blot analysis of extracts from 293 cells treated with EGF 200ng/ml 30', using Breast Tumor Kinase (Phospho-Tyr447) Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of NIH-3T3 cells, using Breast Tumor Kinase (Phospho-Tyr447) Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 2 bis 3 Tage
$302.50
Details
Human Kaninchen Unkonjugiert ELISA, WB Western blot analysis of extracts from LOVO cells, using Breast Tumor Kinase Antibody. The lane on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 2 bis 3 Tage
$302.50
Details
Human Kaninchen Unkonjugiert ELISA, ICC, IF, IHC, WB ABIN6271435 staining 293 by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) Ab, diluted at 1/600, was used as the secondary antibody. ABIN6271435 at 1/200 staining Mouse kidney tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary. 100 μL Anmelden zum Anzeigen 11 bis 12 Tage
$450.00
Details
Human Kaninchen Unkonjugiert IF, ELISA Immunofluorescence analysis of NIH-3T3 cells, using Breast Tumor Kinase (Ab-447) Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 2 bis 3 Tage
$302.50
Details
Human Kaninchen Unkonjugiert IHC (p), WB Western blot analysis of anti-hPTK6-E26 Pab (ABIN392105) in A375 cell line lysate (35 µg/lane). hPTK6-E26(arrow) was detected using the purified polyclonal antibody (1:50 dilution). Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. BC = breast carcinoma. HC = hepatocarcinoma 400 μL Anmelden zum Anzeigen 10 bis 11 Tage
$385.00
Details
Human Maus Unkonjugiert ELISA, WB Figure 1: Western blot analysis using PTK6 mouse mAb against Hela (1), A549 (2) and MCF-7 (3) cell lysate. Dilution: 1/500 - 1/2000 Figure 2: Immunohistochemical analysis of paraffin-embedded maligant mesenchymoma tissues, showing cytoplasmic localization using C-kit mouse mAb with DAB staining. Dilution: 1:200~~1000 100 μL Anmelden zum Anzeigen 10 bis 11 Tage
$577.50
Details
Human Kaninchen Unkonjugiert ELISA, IF, WB 100 μL Anmelden zum Anzeigen 16 Days
$181.73
Details
Human Kaninchen Unkonjugiert EIA, IHC (p), WB 0.4 mL Anmelden zum Anzeigen 6 bis 8 Tage
$484.00
Details

Am meisten referenzierte anti-PTK6 Antikörper

  1. Human Polyclonal PTK6 Primary Antibody für IHC (p), ELISA - ABIN544392 : Coyle, Guzik, Bor, Jin, Eisner-Smerage, Taylor, Rekosh, Hammarskjöld: Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK. in Molecular and cellular biology 2002 (PubMed)
    Show all 3 Pubmed References

  2. Human Polyclonal PTK6 Primary Antibody für IF, WB - ABIN519483 : Foudah, Sallam, Akl, El Sayed: Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors. in European journal of medicinal chemistry 2014 (PubMed)
    Show all 3 Pubmed References

  3. Human Monoclonal PTK6 Primary Antibody für IHC (p), ELISA - ABIN519484 : Akl, Ayoub, Mohyeldin, Busnena, Foudah, Liu, Sayed: Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. in PLoS ONE 2014 (PubMed)
    Show all 2 Pubmed References

  4. Human Polyclonal PTK6 Primary Antibody für IHC (p), WB - ABIN392105 : Derry, Prins, Ray, Tyner: Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. in Oncogene 2003 (PubMed)
    Show all 3 Pubmed References

  5. Human Polyclonal PTK6 Primary Antibody für IF (p), IHC (p) - ABIN1713614 : Akl, Foudah, Ebrahim, Meyer, El Sayed: The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling. in Marine drugs 2014 (PubMed)

  6. Human Monoclonal PTK6 Primary Antibody für ELISA, WB - ABIN969373 : Wilks: Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. in Proceedings of the National Academy of Sciences of the United States of America 1989 (PubMed)
    Show all 4 Pubmed References

  7. Human Monoclonal PTK6 Primary Antibody für ELISA - ABIN966923 : Ottilie, Raulf, Barnekow, Hannig, Schartl: Multiple src-related kinase genes, srk1-4, in the fresh water sponge Spongilla lacustris. in Oncogene 1992 (PubMed)
    Show all 3 Pubmed References

  8. Human Monoclonal PTK6 Primary Antibody für ELISA, WB - ABIN2869234 : Liu, Zhang, Zhong, Li, Liu, Lin, Wu, Zeng: Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma. in Journal of translational medicine 2013 (PubMed)

Weitere Antikörper gegen PTK6 Interaktionspartner

Human PTK6 Protein tyrosine Kinase 6 (PTK6) Interaktionspartner

  1. Using small molecule inhibitors, findings suggest that the kinase activity of PTK6 does not play a significant role in breast tumorigenesis.

  2. In prostate tumor tissue microarrays, loss of PTEN phosphohydrolase (PTEN) correlates with increased tyrosine kinase 6 PTK6 tyrosine 342 (PY342) phosphorylation and poor outcome.

  3. These results indicate that plasma-membrane-associated PTK6 phosphorylates Eps8, which promotes cell proliferation, adhesion, and migration

  4. Expression of PTK6 in established tumors may maintain the epithelial phenotype, preventing tumor progression.

  5. analysis of recombinant PTK6 kinase domain by x-ray crystallography reveals details of its binding to inhibitors

  6. The crystal structure of the kinase domain of human PTK6 has been reported.

  7. PTK6 mRNA and protein levels were elevated in cervical squamous cell cancer and the elevated cytoplasmic expression of PTK6 was associated with tumor grade and short patient survival.

  8. PELP1 interacted with GR to activate Brk expression.

  9. PTK6 prolongs S-phase and increases the ability of gemcitabine to cause DNA damage in vitro and in vivo

  10. BRK expression in a majority of CC can interact with RTK, augmenting growth and interfering with proliferation inhibitors (SAM68). Therapeutically targeting BRK function (in addition to RTK) should be of benefit for CC treatment.

  11. Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression

  12. overexpression or knockdown of PTK6 or ERK1/2 effectively removed the inhibition of S1P-induced migration by miR-17.

  13. Establishment of cross talk between PTK6 and CagA by functional studies may further elucidate the underlying biology of H. pylori-mediated gastric cancer

  14. PTK6 is expressed in the normal human mammary gland, but does not appear to be active and may have kinase-independent functions that are distinct from its cancer promoting activities at the membrane.

  15. Down-regulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.

  16. PTP1B inhibited BRK by dephosphorylating Tyr-342, but activated SRC by antagonizing PAG-dependent inhibition by CSK.

  17. Activating mutations in BRK in breast cancer may disrupt intramolecular interactions that normally maintain BRK in an autoinhibited conformation.

  18. This study shows that Brk phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4.

  19. Hypoxia-induced PTK6 stabilization and subcellular re-localization to the plasma membrane include increased cell motility and invasion, suggesting PTK6 targeting as a therapeutic approach to reduce hypoxia-regulated metastatic potential.

  20. PTK6 regulates cellular migration and invasion in pancreatic cancer via ERK signaling. PTK6 may be a novel therapeutic target for pancreatic cancer.

Mouse (Murine) PTK6 Protein tyrosine Kinase 6 (PTK6) Interaktionspartner

  1. PTK6 may act as a novel mediator of TNFalpha/IFNgamma intestinal epithelial permeability during inflammatory injury, and miR-93 may protect intestinal epithelial barrier function, at least in part, by targeting PTK6

  2. PTK6 prolongs S-phase and increases the ability of gemcitabine to cause DNA damage in vitro and in vivo

  3. Ptk6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.

  4. PTK; expression increases in epidermis following UVB. indicates tumorigenesis in mouse skin.

  5. Protein tyrosine kinase 6 has a role in mediating TNFalpha-induced endothelial barrier dysfunction

  6. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.

  7. expression of Brk/PTK6 in non-transformed mammary epithelial cells mediates p38 MAPK phosphorylation and promotes increased cellular survival, delayed involution, and latent tumor formation.

  8. a novel function for PTK6 at the plasma membrane

  9. PTK6 promotes STAT3 activation in the colon following injection of the carcinogen azoxymethane and regulates STAT3 activity in mouse colon tumors.

  10. AKT is a direct substrate of PTK6 and AKT tyrosine residues 315 and 326 are phosphorylated by PTK6.

  11. PTK6 associates with nuclear and cytoplasmic beta-catenin and inhibits beta-catenin- and T-cell factor (TCF)-mediated transcription.

  12. The tyrosine kinases Brk/PTK6/Sik, Srm, Frk/Rak/Gtk/Iyk/Bsk, and Src42A/Dsrc41 have a low degree of sequence homology to other known kinases. The exon structure of these kinases, called the Brk family, is highly conserved and distinct.

  13. BRK plays a role in differentiation of prostate epithelial cells

  14. ability of tyrposine kinase BRK/Sik to negatively regulate the RNA-binding activities of the KH domain RNA binding proteins SLM-1 and Sam68 may have an impact on the posttranscriptional regulation of epithelial cell gene expression

  15. PTK6 contributes to maintenance of tissue homeostasis through negative regulation of Akt in the small intestine and is associated with cell cycle exit and differentiation in normal intestinal epithelial cells.

  16. Describe a conditionally immortalized colonic epithelial cell line from a Ptk6 null mouse that polarizes and differentiates in vitro.

  17. Brk was found to shorten the latency of ErbB2-induced tumors by promoting cell proliferation, with no effect on protection from apoptosis

PTK6 Antigen-Profil

Protein Überblick

The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants.

Genbezeichner und Symbole assoziert mit PTK6

  • protein tyrosine kinase 6 (PTK6) Antikörper
  • PTK6 protein tyrosine kinase 6 (Ptk6) Antikörper
  • protein tyrosine kinase 6 (Ptk6) Antikörper
  • PTK6 protein tyrosine kinase 6b (ptk6b) Antikörper
  • BRK Antikörper
  • Sik Antikörper
  • tks Antikörper
  • Tksk Antikörper
  • zgc:153964 Antikörper

Bezeichner auf Proteinebene für PTK6

PTK6 protein tyrosine kinase 6 , breast tumor kinase , protein-tyrosine kinase 6 , protein-tyrosine kinase BRK , tyrosine-protein kinase BRK , protein tyrosine kinase 6 , src-related intestinal kinase , tyrosine kinase identified from skin , protein-tyrosine kinase 6-like

GENE ID SPEZIES
5753 Homo sapiens
20459 Mus musculus
366275 Rattus norvegicus
529814 Bos taurus
100060532 Equus caballus
100438236 Pongo abelii
100589028 Nomascus leucogenys
767734 Danio rerio
Ausgewählte Anbieter für anti-PTK6 (PTK6) Antikörper
Haben Sie etwas anderes gesucht?